November 2024 – Page 8 – Goldea Capital

Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care

Written by Customer Service on November 1, 2024. Posted in Public Companies.

Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by renowned physician Dr. Elbaz. This latest agreement is a direct result of the Company’s recent partnership with Axial Biologics, underscoring the success of this collaboration as Milestone’s sales pipeline expands, with additional pilot programs underway in New Jersey, Texas, and Florida. This agreement also follows CompuFlo’s recent Medicare Part B Physician payment rate with...

Northrim BanCorp Announces Acquisition of Sallyport Commercial Finance, LLC

Written by Customer Service on November 1, 2024. Posted in Public Companies.

ANCHORAGE, Alaska, Nov. 01, 2024 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today announced the acquisition of Sallyport Commercial Finance, LLC (“Sallyport” or “SCF”) in an all cash transaction that closed on October 31, 2024 and is valued at approximately $53.9 million. Sallyport Commercial Finance, LLC is a leading provider of factoring, asset based lending and alternative working capital solutions to small and medium sized enterprises in the United States and Canada. The transaction is expected to provide earnings accretion of approximately 15% to Northrim’s 2025 operating results. “Having worked with Nick and the Sallyport team for several years, we have been impressed by the quality of the business they have built,” said Mike Huston, President and CEO of Northrim. “We view this as...

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical

Written by Customer Service on November 1, 2024. Posted in Public Companies.

SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility. “We are pleased to announce the completion of this important acquisition,” said Fred P. Lampropoulos, Merit’s Chairman and Chief Executive Officer. “We are excited to welcome the talented team from Cook Medical’s lead management business. We believe this acquisition will strengthen our fast-growing, high-margin electrophysiology and CRM business,...

Arbe Robotics, Ltd. Announces Pricing of up to $49 Million Public Offering

Written by Customer Service on November 1, 2024. Posted in Public Companies.

$15 million upfront with up to an additional $34 million of aggregate gross proceeds upon the exercise in full for cash of long-term and milestone-linked warrants TEL AVIV, ISRAEL, Nov. 01, 2024 (GLOBE NEWSWIRE) — Arbe Robotics Ltd. (NASDAQ, TASE: ARBE) (“Arbe” or the “Company”), a global leader in Perception Radar Solutions, today announced the pricing of a public offering of an aggregate of 8,250,000 ordinary shares (or pre-funded warrants in lieu thereof) accompanied by Tranche A Warrants to purchase up to 8,250,000 ordinary shares and Tranche B Warrants to purchase up to 8,250,000 ordinary shares, at a combined public offering price of $1.82 per share (or per pre-funded warrant in lieu thereof) and accompanying Tranche A Warrant and Tranche B Warrant. The Tranche A Warrants will have an exercise price of $2.35 per share, will...

ASP Isotopes Announces Pricing of Public Offering of Common Stock

Written by Customer Service on November 1, 2024. Posted in Public Companies.

WASHINGTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”) today announced the pricing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes has agreed to sell an aggregate of 2,395,000 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to ASP Isotopes from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by ASP Isotopes, and without giving effect to any exercise of the underwriters’ option to purchase additional shares, are expected to be approximately $16.2 million. In addition, ASP Isotopes has granted the underwriters a 30-day option to purchase up to 359,250 additional shares of common stock at the public offering price,...

AITX’s RAD Reveals Next Generation Wheeled Security Robot

Written by Customer Service on November 1, 2024. Posted in Public Companies.

ROAMEO Gen 4 ROAMEO Gen 4, the latest in autonomous security technology from AITX’s RAD, stands ready to patrol and protect with unmatched visibility and advanced AI capabilities. ‘ROAMEO Generation 4’ Poised to Fulfill Broad Market Need Detroit, Michigan, Nov. 01, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices, Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), reveals the core specifications for its highly anticipated next generation wheeled robot, ROAMEO™ Generation 4 (Gen 4). After years of development, this mobile robot is scheduled for customer demonstrations beginning in March 2025. This next-generation autonomous security robot is poised to finally fill a long-needed solution in the security and facility management industries: a versatile...

Form 8.3 – [ECKOH PLC – 31 10 2024] – (CGWL)

Written by Customer Service on November 1, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ECKOH PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date position held/dealing...

ATA Creativity Global to Release 2024 Third Quarter Financial Results on November 7

Written by Customer Service on November 1, 2024. Posted in Public Companies.

BEIJING, Nov. 01, 2024 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that it will release financial results for the third quarter and nine-month periods ended September 30, 2024, after the close of the stock market on Thursday, November 7, 2024. A conference call to discuss these results and management’s outlook is scheduled for 8:00 p.m. Eastern Time on Thursday, November 7 (corresponding to 9:00 a.m. Beijing Time on Friday, November 8). Participant Dial-in Numbers U.S. & Canada (Toll-Free): (877) 407-9122 International (Toll): (201) 493-6747 China (Local Access): (400) 120-2840 Hong...

21Shares AG (the “Company”) – Official Notice regarding the update on the name of Exchange Traded Product

Written by Customer Service on November 1, 2024. Posted in Public Companies.

The below was filed with SIX Exchange on 30 October 2024 in accordance with applicable regulations. The original filing can be found here. Official Notice No.: 322516 Title: 21Shares AG (the “Company”) – Official Notice regarding the update on the name ofExchange Traded Product Relevant Exchange Traded Product: ETP: 21Shares Ethereum Core ETPValor Number: 12097631ISIN: CH1209763130Ticker Symbol: ETHCSettlement Currency: USDTrading Currency on SIX: USDPlace of initial listing: SIX Swiss Exchange Name, registered office and address of the Company:21Shares AG is a stock corporation under the laws of Switzerland. It has its registered office and address at Pelikanstrasse 37, 8001 Zurich. On November 19, 2024, the name of the respective Product will be changed as follows: – ISIN being CH1209763130,Old: 21Shares Ethereum...

Galecto Reports Third Quarter 2024 Financial Results

Written by Customer Service on November 1, 2024. Posted in Earnings Releases And Operating Results.

– Completed strategic review to focus on oncology and severe liver diseases – Announced acquisition of global rights to BRM-1420, a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets of AML from Bridge Medicines – Appointed Dr. Amy Wechsler to the Board of Directors and Matthew Kronmiller as Executive Vice President of Strategy and Chief Business Officer BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and severe liver diseases, today reported financial results for the third quarter ended September 30, 2024. “The third quarter was a pivotal period for Galecto highlighted by the completion of a strategic review to prioritize oncology and liver diseases and subsequent acquisition...

Month: November 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice